Femasys is trading 6.56% down at $2.42 after closing at $2.59 on September 18, 2026; the catalyst remains unclear.
- No new company-specific announcement dated September 20–21 was identified; recent coverage concerns earlier September developments, including Minnesota Women’s Care adoption of its fertility portfolio.
- The broader market is higher in pre-market trading, so the decline does not appear market-driven.